Xolair

Research and Markets: Roche/Genentech/Novartis’ Asthma Treatment – Xolair … – Business Wire (press release)

Research and Markets: Roche/Genentech/Novartis' Asthma Treatment – Xolair …Business Wire (press release)Roche/Genentech/Novartis' Xolair (omalizumab) is currently the only FDA-approved biologic used in the treatment of asthma. This drug is a recombinant humanized mAb that binds and neutralizes IgE with the…